ChatRx Opens Community Round, Inviting Patients & Community Members to Invest

ChatRx, the physician-led urgent care platform treating common conditions over chat for $25, opened its Community Round to the public on Wefunder.

PLYMOUTH, IN, UNITED STATES, September 15, 2026 /EINPresswire.com/ -- ChatRx, the physician-led urgent care platform that treats common conditions over chat for a flat $25, opened its Community Round to the public on Wefunder, allowing patients, partners, and community members to invest in the company.

Founded in 2024 by Dr. Tod Stillson, who practiced rural family medicine for thirty years, ChatRx was built to remove the barriers that keep people from seeking care: cost, distance, scheduling, and insurance. Patients describe their symptoms in a private chat; the ChatRx Medical Group reviews the assessment, and when treatment is appropriate, a prescription goes to their local pharmacy. No appointment, no video call, and no waiting room. The symptom assessment is always free.

Since launching in June 2025, ChatRx has completed more than 6,800 assessments for over 5,000 verified users across Indiana, Illinois, and Michigan. More than 60 percent of those assessments end without a prescription, a figure the company cites as evidence that clinical review, not transaction volume, drives outcomes on the platform. ChatRx is FDA Class I registered, LegitScript certified, and HIPAA compliant.

"I spent 30 years watching patients skip care they needed," said Dr. Stillson. "Not because it didn't exist, but because they couldn't afford it, couldn't get to it, or didn't know where to go. We built ChatRx to fix that. Opening this round to our patients felt like the natural next step. The people who rely on ChatRx should have a way to back it."

Dr. Stillson was recently named a 2026-2027 RockHealth.org Innovation Fellow, joining a national cohort of digital health founders.

ChatRx has expanded beyond direct-to-consumer care through partnerships with 15 independent pharmacies, seven northern Indiana school corporations, Marian University Plymouth, and 4C Health, one of Indiana's leading behavioral health organizations. The company has also been named a proposed healthcare navigation technology vendor supporting Indiana's Region 1 GROW rural health initiative, with contracting in progress.

These partnerships are moving ChatRx beyond virtual urgent care toward a broader healthcare navigation network, connecting people with the right level of care at the right time and at a price they can afford.

"Our patients are our best advocates," said Rajeev Ratra, ChatRx's Chief Marketing Officer. "They tell their neighbors, their coworkers, their kids' teachers. Giving them a way to invest in what they're already recommending is the most honest version of a community round we could run."

ChatRx's Wefunder profile and investment details are available at: https://wefunder.com/chatrx
For more information about ChatRx, visit: https://www.chatrx.md

About ChatRx

ChatRx is a physician-led healthcare access and navigation platform serving patients in Indiana, Illinois, and Michigan. Founded in 2024 by Dr. Tod Stillson, ChatRx removes the cost, distance, and scheduling barriers that keep people from seeking care. The platform treats more than 40 acute conditions through a chat-based, asynchronous experience with no insurance, appointment, or office visit required, and works with pharmacies, schools, universities, and community health organizations to connect people with the right level of care. Assessments are free; treatment, when appropriate, is a flat $25.

Important Notice

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to purchase securities. Any securities offering referenced in this release is being made solely through the applicable materials and disclosures provided through Wefunder. Investing in private early-stage companies involves significant risk, including the possible loss of the entire investment.

Dr. Tod Stillson
ChatRx
+1 574-933-2634
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube